Apr 5 |
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
|
Apr 2 |
Goldman starts Mineralys at buy, cites upcoming drug data
|
Mar 22 |
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript
|
Mar 21 |
Mineralys Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 21 |
Mineralys Therapeutics, Inc. (MLYS) Q4 2023 Earnings Call Transcript
|
Mar 21 |
Mineralys Therapeutics files for $500M mixed shelf offering
|
Mar 21 |
Mineralys Therapeutics Inc (MLYS) Reports Increased R&D Expenses Amid Progress in ...
|
Mar 21 |
Mineralys Therapeutics GAAP EPS of -$0.61 beats by $0.21
|
Mar 21 |
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 18 |
Mineralys Therapeutics: A Story To Keep An Eye On
|